Microbicide Trials Network

Image Gallery

The following images are available for download. Unless otherwise noted, please credit Microbicide Trials Network, University of Pittsburgh and Magee-Womens Research Institute. If you have questions about these images or would like additional caption information, please contact Lisa Rossi at rossil@upmc.edu or Clare Collins at collcx@upmc.edu.
 
Microbicides
 
Different
formulations 1
 
Different
formulations 2
microbicide film
 
study gel and
applicator

Tenofovir tablet with gel image
 
 
 

Microbicides can be formulated in different ways.

 
Research
 
 
Research 1
 
Research 2
 
Using a unique tissue explant model that very closely mimics how HIV infects cells of the cervix or rectum, MTN researchers are able to test different products for their safety and effectiveness.
 
 
Research 3
 
Research 4
 
Research 5
 
MTN researchers perform studies that assess the stability of drug compounds in different formulations of microbicides.
 
Research 6
 
MTN researchers look closely for any effects that microbicides may have on the normal population of vaginal microflora, studies that are important for assessing the safety of different products.
 
People
 
Ward Cates
FHI Principal Investigator
Credit: Family Health International
Connie Celum
Co-Principal Investigator
Credit: University of Washington
Charlene Dezzutti       
Principal Investigator Network Laboratory
 
Sharon Hillier
Principal Investigator
 
Ben Masse
Statistical Data and Monitoring Center PI
Credit: Statistical Center for HIV/AIDS Research & Prevention          
 
Ian McGowan
Co-principal investigator
 
Credit: Adam Milliron

 
Graphics and Illustrations
 
 
HIV infects T cells, one of several immune system cells, which have a specific molecule on its surface called a CD4 receptor. The receptor serves as a docking station where HIV sits before invading the cell. T cells are not found on the surface of the vagina, but below the epithelium, these and other target cells are found in abundance. How HIV reaches these cells is not certain. Perhaps HIV hitches a ride with dendritic cells that straddle the two layers, having conveniently been captured by these cells as an “invader” to be turned over to T cells and other immune cells that would otherwise orchestrate an attack. Or maybe the virus uses more direct routes through breaks in the tissue caused by local trauma and/or a sexually transmitted infection.